| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cost of Revenue | $149K | +404.0% | — |
| Gross Profit | -$22K | +98.2% | — |
| R&D Expense | $4.5M | +23.8% | +2.1% |
| SG&A Expense | $9.5M | +10.4% | +19.0% |
| Operating Income | -$14.0M | -4.0% | -13.2% |
| Pre-tax Income | -$4.5M | — | +90.4% |
| Income Tax | $3K | — | +0.0% |
| Net Income | -$4.5M | +80.7% | +90.4% |
| EPS (Basic) | -$0.05 | +86.8% | +96.7% |
| EPS (Diluted) | -$0.05 | +86.8% | +96.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.7M | -10.7% | +2.5% |
| Accounts Receivable | $2.7M | +2273.1% | — |
| Inventory | $3.3M | -3.3% | -7.2% |
| Current Assets | $20.9M | +21.8% | +17.4% |
| Total Assets | $21.9M | +20.0% | +14.8% |
| Current Liabilities | $38.9M | -20.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.8M | -52.4% | — |
| Financing Cash Flow | $22.4M | +44.4% | — |
| +56.6% |
| Total Liabilities | $50.9M | -10.4% | -1.3% |
| Stockholders' Equity | -$29.0M | +24.8% | +10.7% |